Registration area for 2008 APSA Annual Meeting
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition. The 2009 Lasker~DeBakey Clinical Medical Research Award honors three scientists who developed novel treatments for chronic myeloid leukemia (CML) that converted this fatal cancer into a manageable chronic condition. By targeting the molecular underpinnings of this disease, Brian J. Druker (Oregon Health & Science University), Nicholas B. Lydon (formerly, Novartis), and Charles L. Sawyers (Memorial Sloan-Kettering Cancer Center) broke new ground in cancer therapy and radically altered the prognosis of CML patients.
1 week 9 hours ago
The Keystone Symposia Fellows Program - Now Taking Applications http://fb.me/BZCyETTb
1 week 1 day ago
House Panel Approves 3.2% Raise for NIH in 2011 http://fb.me/EP19f2Ye
1 week 2 days ago
Veterinarian Scientists Bring Unique Perspectives to Translational Research http://fb.me/ymWiwJVu